Studies related to PMS and Zinc

Effect Of Zinc Supplementation On Physical And Psychological Symptoms, Biomarkers Of Inflammation, Oxidative Stress, And Brain-Derived Neurotrophic Factor In Young Women With Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Effect Decrease
Values Physical symptoms. Mean + SD. Placebo: before 0.47 ± 0.31, after 0.45 ± 0.3. Zinc: before 0.66 ± 0.62, after 0.32 ± 0.29. Psychological symptoms: Placebo: before 0.47 ± 0.29, after 0.48 ± 0.4. Intervention: before 0.62 ± 0.43, after 0.31 ± 0.36.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 60
Sex Female
Age Range 18-29, 30-44
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 60 women with premenstrual syndrome were allocated to take 30 mg of zinc gluconate or placebo for 12 weeks.

At the end of 12 weeks, the average score for psychological and physical symptoms improved considerably in the zinc group but not the placebo group. Additionally, the zinc group saw a greater increase in BDNF and total antioxidant capacity, and greater decrease in hs-CRP.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.